726 50 WATSON (Meperidine 50 mg)
Pill imprint 726 50 WATSON has been identified as Meperidine hydrochloride 50 mg.
Meperidine is used in the treatment of pain; light sedation and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Meperidine 50 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Meperidine hydrochloride
- Imprint:
- 726 50 WATSON
- Strength:
- 50 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0726
- Inactive Ingredients:
- confectioners sugar
lactose monohydrate
magnesium stearate
povidone
sodium starch glycolate
More about meperidine
Consumer resources
- Meperidine
- Meperidine syrup
- Meperidine tablets
- Meperidine (Advanced Reading)
- Meperidine Injection (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
